Samsara Bio Capital, LLC Pep Gen Inc. Transaction History

Samsara Bio Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.86 - $7.96 $826,954 - $1.71 Million	-214,237 Reduced 32.91%	436,813 $2.97 Million
Q1 2023 May 15, 2023	BUY	$11.44 - $17.7 $7.45 Million - $11.5 Million	651,050 New	651,050 $7.96 Million
Q2 2022 Aug 15, 2022	BUY	$9.0 - $12.89 $5.86 Million - $8.39 Million	651,050 New	651,050 $6.47 Million

25.2M

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $85.8M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.